Gbolahan Somoye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gbolahan Somoye has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
David Parkin
Ward 42, Aberdeen Royal Infirmary
2 shared publications- Fiona J. Gilbert
University of Cambridge
1 shared publication Gail Fullerton
Aberdeen Royal Infirmary
1 shared publicationGeorge Plataniotis
Musgrove Park Hospital
1 shared publicationH Lawton
1 shared publication- Neil W. Scott
Biostatistics and Health Data Science, University of Aberdeen, Aberdeen, UK
1 shared publication
Latest Publications
- 1 June 2012
- Published by Springer Nature in European Radiology
- Vol. 22 (11) , 2319-2327
Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation
To assess the predictive value of diffusion weighted imaging (DWI) for survival in women treated for advanced cancer of the cervix with concurrent chemo-radiotherapy.
- 1 June 2012
- Published by Springer Nature in European Radiology
- Vol. 22 (11) , 2319-2327
Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation
To assess the predictive value of diffusion weighted imaging (DWI) for survival in women treated for advanced cancer of the cervix with concurrent chemo-radiotherapy.
- 24 September 2009
- Published by Springer Nature in Gynecological Surgery
- Vol. 7 (2) , 177-180
Bilateral hydrosalpinges masquerading as ovarian cancer: a late complication of microwave endometrial ablation: a case report and literature review
- 24 September 2009
- Published by Springer Nature in Gynecological Surgery
- Vol. 7 (2) , 177-180
Bilateral hydrosalpinges masquerading as ovarian cancer: a late complication of microwave endometrial ablation: a case report and literature review
- 1 January 2009
- Vol. 30 (6) , 664-7
Endometrial stromal sarcoma: experience from a district hospital and literature review.
Endometrial stromal sarcoma (ESS) is a rare malignancy of the uterus. Most cases are incidentally diagnosed on histological examination of hysterectomy specimens. Evidence on the management is accrued mainly from retrospective studies. This study aims to review the clinical experience of a district hospital in the diagnosis and management of this rare tumour over a 12-year period. Information on cases of ESS from 1995 to 2007 were retrieved from the histological database. All case files of identified patients were analysed and data extrapolated. A literature review was performed. There were seven cases identified over this time period highlighting the rarity of ESS. Most cases were low-grade ESS and diagnosed retrospectively following surgery for presumed benign pathology. Cases with high-grade ESS and advanced stage low-grade ESS received adjuvant therapy. The primary treatment of ESS is surgery. The role of adjuvant therapy remains debatable, but generally involves radiotherapy, chemotherapy and hormonal therapy Optimal treatment protocols may be achieved by the conduct of randomised controlled clinical trials.
- 1 January 2009
- Vol. 30 (6) , 664-7
Endometrial stromal sarcoma: experience from a district hospital and literature review.
Endometrial stromal sarcoma (ESS) is a rare malignancy of the uterus. Most cases are incidentally diagnosed on histological examination of hysterectomy specimens. Evidence on the management is accrued mainly from retrospective studies. This study aims to review the clinical experience of a district hospital in the diagnosis and management of this rare tumour over a 12-year period. Information on cases of ESS from 1995 to 2007 were retrieved from the histological database. All case files of identified patients were analysed and data extrapolated. A literature review was performed. There were seven cases identified over this time period highlighting the rarity of ESS. Most cases were low-grade ESS and diagnosed retrospectively following surgery for presumed benign pathology. Cases with high-grade ESS and advanced stage low-grade ESS received adjuvant therapy. The primary treatment of ESS is surgery. The role of adjuvant therapy remains debatable, but generally involves radiotherapy, chemotherapy and hormonal therapy Optimal treatment protocols may be achieved by the conduct of randomised controlled clinical trials.